Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-24-026015
Filing Date
2024-05-31
Accepted
2024-05-31 15:34:17
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 gri-prosuppno8todec2023sx1a.htm 424B3 28723
2 image_02.jpg GRAPHIC 39812
3 image_0a.jpg GRAPHIC 16879
4 image_8.jpg GRAPHIC 1656
  Complete submission text file 0001628280-24-026015.txt   110507
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-274972 | Film No.: 241009341
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)